梅努菲亚大学隔离医院COVID-19患者的细菌生物图谱

IF 0.2 Q4 RESPIRATORY SYSTEM
G. Abdelaal, E. El-Masry, Sami Eldahdouh
{"title":"梅努菲亚大学隔离医院COVID-19患者的细菌生物图谱","authors":"G. Abdelaal, E. El-Masry, Sami Eldahdouh","doi":"10.4103/ecdt.ecdt_3_22","DOIUrl":null,"url":null,"abstract":"Background The evaluation of coronavirus disease 2019 (COVID-19) patients with respiratory secondary bacterial infection, and the causative pathogens, is crucial for the treatment plan of those patients and to ensure the effective needed treatment with antibiotics and to decrease its abuse. Aim To clarify the incidence of bacterial infection in patients with COVID-19 and sensitivity to antibiotics. Patients and methods Samples of sputum were collected from 120 patients with confirmed COVID-19 by clinical, laboratory, radiological signs of pneumonia, or PCR, the severity of COVID-19 was classified as moderate and severe. The moderate type included patients with pneumonia without hypoxemia. The severe type was characterized by (a) dyspnea (respiratory rate ≥30/min), (b) blood oxygen saturation less than or equal to 93%, and (c) PaO2/FiO2 ratio less than 300 or lung infiltrates more than 50%. If one of the above items was met, it was classified as severe. Then, all cases were sent for screening of the presence of secondary bacterial infections by quantitative sputum bacterial culture and sensitivity. Positive cases of bacterial infection were classified into patients with early bacterial infection less than 15 days from COVID-19 infection and patients with late bacterial infections after more than 15 days of COVID-19 infection. Results In total, 40 (33.3%) cases out of 120 cases of COVID-19 showed bacterial growth, while 80 (66.7%) cases were negative for bacterial secondary infection. The most common organisms isolated were Klebsiella pneumoniae 12 cases, streptococci 10 cases, MERSA eight cases, Escherichia coli five cases and mixed infection by E. coli, Klebsiella, and Candida in five cases, Staphylococcus aureus was the same rate in early and late infections, all streptococci were early infection, and more cases of K. pneumoniae were late infection nine cases out of 13, where E. coli was early infection four cases out of five. All mixed infections were late. Conclusion Hidden secondary bacterial infection should be screened in COVID-19 patients. Early bacterial infections and moderate COVID-19 pneumonia are mainly caused by Gram-positive bacteria, but late bacterial infections and severe COVID-19 pneumonia are mainly caused by Gram-negative bacteria.","PeriodicalId":46359,"journal":{"name":"Egyptian Journal of Chest Diseases and Tuberculosis","volume":"8 1","pages":"433 - 440"},"PeriodicalIF":0.2000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bacterial biogram in COVID-19 patients in Menoufia University isolation hospitals\",\"authors\":\"G. Abdelaal, E. El-Masry, Sami Eldahdouh\",\"doi\":\"10.4103/ecdt.ecdt_3_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background The evaluation of coronavirus disease 2019 (COVID-19) patients with respiratory secondary bacterial infection, and the causative pathogens, is crucial for the treatment plan of those patients and to ensure the effective needed treatment with antibiotics and to decrease its abuse. Aim To clarify the incidence of bacterial infection in patients with COVID-19 and sensitivity to antibiotics. Patients and methods Samples of sputum were collected from 120 patients with confirmed COVID-19 by clinical, laboratory, radiological signs of pneumonia, or PCR, the severity of COVID-19 was classified as moderate and severe. The moderate type included patients with pneumonia without hypoxemia. The severe type was characterized by (a) dyspnea (respiratory rate ≥30/min), (b) blood oxygen saturation less than or equal to 93%, and (c) PaO2/FiO2 ratio less than 300 or lung infiltrates more than 50%. If one of the above items was met, it was classified as severe. Then, all cases were sent for screening of the presence of secondary bacterial infections by quantitative sputum bacterial culture and sensitivity. Positive cases of bacterial infection were classified into patients with early bacterial infection less than 15 days from COVID-19 infection and patients with late bacterial infections after more than 15 days of COVID-19 infection. Results In total, 40 (33.3%) cases out of 120 cases of COVID-19 showed bacterial growth, while 80 (66.7%) cases were negative for bacterial secondary infection. The most common organisms isolated were Klebsiella pneumoniae 12 cases, streptococci 10 cases, MERSA eight cases, Escherichia coli five cases and mixed infection by E. coli, Klebsiella, and Candida in five cases, Staphylococcus aureus was the same rate in early and late infections, all streptococci were early infection, and more cases of K. pneumoniae were late infection nine cases out of 13, where E. coli was early infection four cases out of five. All mixed infections were late. Conclusion Hidden secondary bacterial infection should be screened in COVID-19 patients. Early bacterial infections and moderate COVID-19 pneumonia are mainly caused by Gram-positive bacteria, but late bacterial infections and severe COVID-19 pneumonia are mainly caused by Gram-negative bacteria.\",\"PeriodicalId\":46359,\"journal\":{\"name\":\"Egyptian Journal of Chest Diseases and Tuberculosis\",\"volume\":\"8 1\",\"pages\":\"433 - 440\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Journal of Chest Diseases and Tuberculosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ecdt.ecdt_3_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Chest Diseases and Tuberculosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ecdt.ecdt_3_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景2019冠状病毒病(COVID-19)并发呼吸道继发性细菌感染患者及其致病病原体的评估,对于制定患者的治疗方案、确保抗生素的有效治疗和减少抗生素的滥用至关重要。目的了解新冠肺炎患者细菌感染的发生率及对抗生素的敏感性。患者和方法收集120例经临床、实验室、肺炎放射学征象或PCR确诊的COVID-19患者的痰液样本,将COVID-19严重程度分为中度和重度。中度包括无低氧血症的肺炎患者。重症以(a)呼吸困难(呼吸频率≥30/min), (b)血氧饱和度小于或等于93%,(c) PaO2/FiO2小于300或肺浸润大于50%为特征。如果满足上述条件之一,则被列为严重。然后,通过定量痰细菌培养和敏感性筛查所有病例是否存在继发性细菌感染。细菌感染阳性病例分为感染时间小于15天的早期细菌感染患者和感染时间大于15天的晚期细菌感染患者。结果120例新冠肺炎患者中,细菌生长40例(33.3%),细菌继发感染阴性80例(66.7%)。最常见的细菌是肺炎克雷伯菌12例,链球菌10例,mers 8例,大肠埃希菌5例,大肠埃希菌、克雷伯菌和念珠菌混合感染5例,金黄色葡萄球菌早、晚期感染率相同,所有链球菌均为早期感染,肺炎克雷伯菌晚期感染较多,13例中有9例为早期感染,大肠埃希菌早期感染4例。所有混合感染均为晚期。结论COVID-19患者应筛查隐性继发细菌感染。早期细菌感染和中度COVID-19肺炎主要由革兰氏阳性菌引起,晚期细菌感染和重度COVID-19肺炎主要由革兰氏阴性菌引起。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Bacterial biogram in COVID-19 patients in Menoufia University isolation hospitals
Background The evaluation of coronavirus disease 2019 (COVID-19) patients with respiratory secondary bacterial infection, and the causative pathogens, is crucial for the treatment plan of those patients and to ensure the effective needed treatment with antibiotics and to decrease its abuse. Aim To clarify the incidence of bacterial infection in patients with COVID-19 and sensitivity to antibiotics. Patients and methods Samples of sputum were collected from 120 patients with confirmed COVID-19 by clinical, laboratory, radiological signs of pneumonia, or PCR, the severity of COVID-19 was classified as moderate and severe. The moderate type included patients with pneumonia without hypoxemia. The severe type was characterized by (a) dyspnea (respiratory rate ≥30/min), (b) blood oxygen saturation less than or equal to 93%, and (c) PaO2/FiO2 ratio less than 300 or lung infiltrates more than 50%. If one of the above items was met, it was classified as severe. Then, all cases were sent for screening of the presence of secondary bacterial infections by quantitative sputum bacterial culture and sensitivity. Positive cases of bacterial infection were classified into patients with early bacterial infection less than 15 days from COVID-19 infection and patients with late bacterial infections after more than 15 days of COVID-19 infection. Results In total, 40 (33.3%) cases out of 120 cases of COVID-19 showed bacterial growth, while 80 (66.7%) cases were negative for bacterial secondary infection. The most common organisms isolated were Klebsiella pneumoniae 12 cases, streptococci 10 cases, MERSA eight cases, Escherichia coli five cases and mixed infection by E. coli, Klebsiella, and Candida in five cases, Staphylococcus aureus was the same rate in early and late infections, all streptococci were early infection, and more cases of K. pneumoniae were late infection nine cases out of 13, where E. coli was early infection four cases out of five. All mixed infections were late. Conclusion Hidden secondary bacterial infection should be screened in COVID-19 patients. Early bacterial infections and moderate COVID-19 pneumonia are mainly caused by Gram-positive bacteria, but late bacterial infections and severe COVID-19 pneumonia are mainly caused by Gram-negative bacteria.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
46
审稿时长
22 weeks
期刊介绍: The journal will cover technical and clinical studies related to health, ethical and social issues in field of The Egyptian Journal of Chest Diseases and Tuberculosis aims to publish and inform readers and all chest physicians of the progress in medical research concerning all aspect of chest diseases. Publications include original articles review articles, editorials, case studies and reports which are relevant to chest diseases. The Journal also aims to highlight recent updates in chest medicine. . Articles with clinical interest and implications will be given preference.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信